The IMCA-CAT Subscription program provides pharmaceutical and biotech companies, that are not members of IMCA, the opportunity to conduct proprietary experiments at the IMCA-CAT insertion device beamline.

Subscription are annual, renewable agreements that are customizable to meet the needs of individual drug discovery program.

Automated sample mounting, diffraction rastering for high precision sample centering, and shutterless continuous-rotation data collection distinguish IMCA-CAT as an outstanding research environment for confidential and proprietary structural biology programs in the pharmaceutical industry.